Basilea Pharmaceutica (BPMUF) Stock Forecast & Price Target $54.00 0.00 (0.00%) As of 03/31/2025 Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Basilea Pharmaceutica - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Strong BuyBased on 1 Analyst RatingsSell0Hold0Buy1 Based on 1 Wall Street analysts who have issued ratings for Basilea Pharmaceutica in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 1 analysts, 1 has given a strong buy rating for BPMUF. Consensus Price Target N/A Get the Latest News and Ratings for BPMUF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Basilea Pharmaceutica and its competitors. Enter your email to sign up for newsletter Sign Up BPMUF Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s) N/A Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s) N/A Hold0 Hold rating(s)0 Hold rating(s)0 Hold rating(s) N/A Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s) N/A Consensus Price TargetN/AN/AN/AN/AForecasted UpsideN/AN/AN/AN/AConsensus RatingStrong BuyStrong BuyStrong BuyN/A Remove Ads BPMUF Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History BPMUF Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Basilea Pharmaceutica Stock vs. The CompetitionTypeBasilea PharmaceuticaMedical CompaniesS&P 500Consensus Rating Score 4.00 2.82 2.54Consensus RatingStrong BuyModerate BuyModerate BuyPredicted UpsideN/A19,856.82% Upside19.02% UpsideNews Sentiment RatingPositive NewsSee Recent BPMUF NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails9/23/2024HC Wainwright1 of 5 starsR. SelvarajuSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:58 AM ET. BPMUF Forecast - Frequently Asked Questions Should I buy or sell Basilea Pharmaceutica stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Basilea Pharmaceutica in the last year. There is currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" BPMUF shares. Does Basilea Pharmaceutica's stock price have much downside? According to analysts, Basilea Pharmaceutica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts. Do Wall Street analysts like Basilea Pharmaceutica more than its competitors? Analysts like Basilea Pharmaceutica more than other "medical" companies. The consensus rating for Basilea Pharmaceutica is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BPMUF compares to other companies. Stock Forecasts and Research Tools Related Companies ACADIA Pharmaceuticals Stock Forecast Biohaven Stock Forecast ImmunityBio Stock Forecast HUTCHMED Stock Forecast Xenon Pharmaceuticals Stock Forecast Amneal Pharmaceuticals Stock Forecast MoonLake Immunotherapeutics Stock Forecast Bausch Health Companies Stock Forecast Twist Bioscience Stock Forecast NewAmsterdam Pharma Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (OTCMKTS:BPMUF) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basilea Pharmaceutica AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Basilea Pharmaceutica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPMUF Stock Free BPMUF Stock Alerts